Utah Medical Products (NASDAQ: UTMD) is one of 84 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it compare to its peers? We will compare Utah Medical Products to similar companies based on the strength of its earnings, risk, valuation, analyst recommendations, profitability, institutional ownership and dividends.
Valuation & Earnings
This table compares Utah Medical Products and its peers top-line revenue, earnings per share (EPS) and valuation.
Utah Medical Products’ peers have higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Institutional and Insider Ownership
66.8% of Utah Medical Products shares are held by institutional investors. Comparatively, 66.2% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by institutional investors. 9.1% of Utah Medical Products shares are held by company insiders. Comparatively, 10.9% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
This is a summary of recent ratings and target prices for Utah Medical Products and its peers, as provided by MarketBeat.com.
As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 8.10%. Given Utah Medical Products’ peers higher possible upside, analysts clearly believe Utah Medical Products has less favorable growth aspects than its peers.
Utah Medical Products pays an annual dividend of $1.06 per share and has a dividend yield of 1.4%. Utah Medical Products pays out 30.4% of its earnings in the form of a dividend. As a group, “Medical Equipment, Supplies & Distribution” companies pay a dividend yield of 0.8% and pay out 37.4% of their earnings in the form of a dividend. Utah Medical Products is clearly a better dividend stock than its peers, given its higher yield and lower payout ratio.
Volatility & Risk
Utah Medical Products has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500. Comparatively, Utah Medical Products’ peers have a beta of 1.06, indicating that their average stock price is 6% more volatile than the S&P 500.
This table compares Utah Medical Products and its peers’ net margins, return on equity and return on assets.
Utah Medical Products Company Profile
Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. UTMD markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit, the labor and delivery department and the women’s health center in hospitals, as well as products sold to outpatient clinics and physician’s offices.